Scilex Holding Co (SCLX)
0.8655
+0.01
(+0.64%)
USD |
NASDAQ |
May 06, 16:00
0.8583
-0.01
(-0.83%)
After-Hours: 20:00
Scilex Cash from Operations (TTM): -20.71M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -20.71M |
September 30, 2023 | -16.04M |
June 30, 2023 | -19.41M |
Date | Value |
---|---|
March 31, 2023 | -18.27M |
December 31, 2022 | -21.26M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-21.26M
Minimum
Dec 2022
-16.04M
Maximum
Sep 2023
-19.14M
Average
-19.41M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
Sorrento Therapeutics Inc | -234.63M |
Adial Pharmaceuticals Inc | -6.807M |
Precision BioSciences Inc | -84.11M |
Humacyte Inc | -73.30M |
Perspective Therapeutics Inc | -36.91M |